Medtech stocks closed May at their highest point since before the COVID-19 pandemic rocked the markets. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — sat at 87.17 points at the end of last week (May 29). That total represents a 2.3% gain from the 85.22-point total at the […]
Haemonetics
Haemonetics sells off blood donor software
Haemonetics (NYSE:HAE) announced today that it plans to sell certain blood donor management software assets to the GPI Group. GPI, a provider of IT solutions for healthcare and social services, is purchasing the assets from within Haemonetics’ blood center business unit, according to a news release. Under the agreement, Boston-based Haemonetics and its subsidiary Global Med […]
MedTech 100 roundup: Stocks open strong in May
Medtech stocks took a dip as April came to a close, but opened May with a strong week as the COVID-19 pandemic continues to affect the economy. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — sat at 83.98 points at the end of last week (May 8). That […]
Haemonetics slides on missed 4Q projections
Haemonetics (NYSE:HAE) shares slid today on fourth-quarter results that came up short compared to the consensus forecast. The Boston-based company posted profits of $17.6 million, or 34¢ per share, on sales of $238.5 million for the three months ended March 28, 2020, for a -15.4% bottom-line slide on a sales decline of -4.3%. Adjusted to exclude […]
Haemonetics acquires Enicor
Haemonetics (NYSE:HAE) announced that it acquired next-generation whole blood coagulation testing system developer Enicor GmbH for an undisclosed amount. Munich, Germany-based Enicor develops the ClotPro system designed for viscoelastic diagnostics touted to offer more assays than any other hemostasis analyzer on the market. Haemonetics said in a news release that ClotPro is set to be coupled […]
Haemonetics posts Street-beating Q3 results
Haemonetics (NYSE:HAE) posted third-quarter results today that beat the consensus forecast on Wall Street and reaffirmed its total revenue guidance. The news sent shares in HAE up more than 9%. The Boston-based company reported profits of $29.9 million, or 58¢ per share, on sales of $259 million for the three months ended Dec. 31, 2019, for […]
Haemonetics buys hemostasis analyzer IP
Haemonetics (NYSE:HAE) announced today that it purchased the technology underlying the TEG 6s hemostasis analyzer system from CoraMed Technologies. Braintree, Mass.-based Haemonetics now owns the intellectual property it previously licensed from CoraMed for use in hospitals and hospital laboratories, and may pursue site-of-care opportunities beyond hospitals. TEG 6s includes an analyzer, disposable cartridges and software designed […]
Haemonetics opens new Boston headquarters
Haemonetics (NYSE:HAE) said this week it opened its new global headquarters in Boston. The new location will help the company bring together its corporate and commercial teams with its research and development organization. “Relocating our headquarters to Boston is an important step in Haemonetics’ transformation,” president and CEO Chris Simon said. “Our new downtown location in […]
Haemonetics (HAE) launches SafeTrace Tx in North America
Haemonetics (NYSE:HAE) announced that it commercially launched the next generation of its SafeTrace TX transfusion management software in North America. SafeTrace TX is a specialized transfusion management system used in the blood bank for managing patient and blood product information and assisting in determining blood product suitability for patient transfusion. The updated software is designed to […]
Haemonetics beats Wall Street on Q1 EPS, revenue
Haemonetics (NYSE:HAE) posted first-quarter 2020 results today that beat the consensus forecast on Wall Street and boosted its fiscal 2020 EPS guidance. The Braintree, Mass.-based medical device maker reported a loss of -$8.48million, or -$0.17 per share, on sales of $238.5 million for the three months ended June 29, 2019, for a bottom-line loss of […]
Haemonetics wins expanded FDA nod for TEG 6s hemostasis analyzer
Haemonetics (NYSE:HAE) said on Monday that it won expanded FDA 510(k) clearance for its TEG 6s hemostasis analyzer system, now indicated for use in adult trauma settings. The TEG 6s system is comprised of an analyzer, disposable cartridges and software and is intended to provide a rapid and accurate identification of a patient’s hemostasis condition, the […]
